Filing Details
- Accession Number:
- 0000315066-17-002230
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-15 16:17:59
- Reporting Period:
- 2017-03-13
- Filing Date:
- 2017-03-15
- Accepted Time:
- 2017-03-15 16:17:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1445283 | Proteostasis Therapeutics Inc. | PTI | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 315066 | Fmr Llc | 245 Summer Street Boston MA 02210 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-03-13 | 25,000 | $12.94 | 243,508 | No | 4 | S | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See Footnote |
Footnotes
- By Impresa Fund III Limited Partnership (238,685 shares of Common Stock) and F-Prime Inc. (4,823 shares of Common Stock). Impresa Fund III Limited Partnership is solely managed by Impresa Management LLC, its general partner and investment manager. Impresa Management LLC is owned, directly or indirectly, by various shareholders and employees of FMR LLC, including certain members of the Johnson family. F-Prime Inc. is a wholly-owned subsidiary of FMR LLC.
- The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $12.21 to $13.18. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
